9
Views
6
CrossRef citations to date
0
Altmetric
Articles

Bactericidal Activity of Moxifloxacin Compared to Grepafloxacin and Clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes Investigated Using an In Vitro Pharmacodynamic Model

Pages 475-481 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David RP Guay. (2006) Moxifloxacin in the treatment of skin and skin structure infections. Therapeutics and Clinical Risk Management 2:4, pages 417-434.
Read now

Articles from other publishers (5)

Benjamin A. Lipsky, Philip Giordano, Shurjeel Choudhri & James Song. (2007) Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate. Journal of Antimicrobial Chemotherapy 60:2, pages 370-376.
Crossref
Richard M. Rosenfeld, Charles D. Bluestone, Margaretha L. Casselbrant, Tasnee Chonmaitree, Jan J. Grote, Mark P. Haggard, Jorgen Lous, Paola Marchisio, Jack L. Paradise, Karin Prellner, Anne G. M. Schilder & Sven-Eric Stangerup. (2016) 8. Treatment. Annals of Otology, Rhinology & Laryngology 114:1_suppl, pages 114-139.
Crossref
Gillian M Keating & Lesley J Scott. (2004) Moxifloxacin. Drugs 64:20, pages 2347-2377.
Crossref
Masahiro Takahata, Hiroshi Yamada, Teiichi Morita, Shinichi Furubou, Shinzaburo Minami, Yozo Todo, Yasuo Watanabe & Hirokazu Narita. (2002) Evaluation of T-3811ME (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae in Rabbits. Antimicrobial Agents and Chemotherapy 46:6, pages 1760-1765.
Crossref
Alasdair MacGowan & Karen Bowker. (2002) Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models. International Journal of Antimicrobial Agents 19:4, pages 291-298.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.